- Home
- NEO vs IRMD Comparison
NEO vs IRMD Comparison
Compare NEO & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- IRMD
- Stock Information
- Founded
- NEO 2001
- IRMD 1992
- Country
- NEO United States
- IRMD United States
- Employees
- NEO N/A
- IRMD N/A
- Industry
- NEO Precision Instruments
- IRMD Medical/Dental Instruments
- Sector
- NEO Health Care
- IRMD Health Care
- Exchange
- NEO Nasdaq
- IRMD Nasdaq
- Market Cap
- NEO 709.2M
- IRMD 756.5M
- IPO Year
- NEO 1999
- IRMD 2014
- Fundamental
- Price
- NEO $6.61
- IRMD $72.66
- Analyst Decision
- NEO Buy
- IRMD Strong Buy
- Analyst Count
- NEO 8
- IRMD 1
- Target Price
- NEO $12.00
- IRMD $72.00
- AVG Volume (30 Days)
- NEO 3.0M
- IRMD 58.7K
- Earning Date
- NEO 07-29-2025
- IRMD 08-01-2025
- Dividend Yield
- NEO N/A
- IRMD 0.94%
- EPS Growth
- NEO N/A
- IRMD 10.28
- EPS
- NEO N/A
- IRMD 1.61
- Revenue
- NEO $689,189,000.00
- IRMD $77,635,163.00
- Revenue This Year
- NEO $13.83
- IRMD $13.76
- Revenue Next Year
- NEO $11.35
- IRMD $10.38
- P/E Ratio
- NEO N/A
- IRMD $44.99
- Revenue Growth
- NEO 9.70
- IRMD 11.73
- 52 Week Low
- NEO $4.72
- IRMD $44.30
- 52 Week High
- NEO $19.12
- IRMD $73.47
- Technical
- Relative Strength Index (RSI)
- NEO 58.15
- IRMD 71.36
- Support Level
- NEO $5.94
- IRMD $69.44
- Resistance Level
- NEO $6.35
- IRMD $71.06
- Average True Range (ATR)
- NEO 0.26
- IRMD 1.89
- MACD
- NEO 0.12
- IRMD 0.00
- Stochastic Oscillator
- NEO 99.20
- IRMD 86.41
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.